|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
389,580,000 |
Market
Cap: |
49.62(B) |
Last
Volume: |
2,275,563 |
Avg
Vol: |
1,913,967 |
52
Week Range: |
$75.49 - $140.45 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 487 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
213,540 |
278,390 |
302,534 |
572,658 |
Total Sell Value |
$28,796,122 |
$36,739,208 |
$39,473,632 |
$69,793,485 |
Total People Sold |
7 |
9 |
14 |
15 |
Total Sell Transactions |
14 |
25 |
45 |
79 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Dahut Karen M |
Director |
|
2020-08-11 |
4 |
A |
$0.00 |
$1 |
D/D |
1,160 |
1,160 |
|
- |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2020-08-10 |
4 |
AS |
$439.31 |
$219,655 |
D/D |
(500) |
28,176 |
|
-17% |
|
Altman Steven R |
Director |
|
2020-08-10 |
4 |
AS |
$431.77 |
$870,093 |
I/I |
(2,000) |
42,980 |
|
-17% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2020-08-10 |
4 |
AS |
$439.31 |
$175,724 |
D/D |
(400) |
22,041 |
|
-17% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2020-07-23 |
4 |
AS |
$421.62 |
$654,188 |
I/I |
(1,531) |
3,060 |
|
-18% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2020-07-23 |
4 |
AS |
$421.62 |
$654,213 |
D/D |
(1,531) |
74,408 |
|
-18% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2020-07-10 |
4 |
AS |
$439.33 |
$175,732 |
D/D |
(400) |
22,441 |
|
-25% |
|
Altman Steven R |
Director |
|
2020-07-10 |
4 |
AS |
$433.73 |
$874,993 |
I/I |
(2,000) |
44,980 |
|
-25% |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2020-07-09 |
4 |
AS |
$435.80 |
$217,900 |
D/D |
(500) |
28,676 |
|
-25% |
|
Sayer Kevin R |
President, CEO and Chairman |
|
2020-07-06 |
4 |
AS |
$408.87 |
$2,525,662 |
D/D |
(6,000) |
152,542 |
|
-21% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2020-06-23 |
4 |
AS |
$407.18 |
$626,750 |
D/D |
(1,531) |
75,939 |
|
-18% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2020-06-23 |
4 |
AS |
$407.13 |
$626,807 |
I/I |
(1,531) |
4,591 |
|
-18% |
|
Augustinos Nicholas |
Director |
|
2020-06-15 |
4 |
AS |
$362.47 |
$687,463 |
I/I |
(1,875) |
15,717 |
|
5% |
|
Balo Andrew K |
* |
|
2020-06-15 |
4 |
AS |
$359.98 |
$2,390,096 |
D/D |
(6,522) |
45,376 |
|
5% |
|
Leach Jacob Steven |
EVP Chief Technology Officer |
|
2020-06-11 |
4 |
AS |
$372.97 |
$7,207,029 |
D/D |
(19,129) |
107,369 |
|
9% |
|
Altman Steven R |
Director |
|
2020-06-10 |
4 |
AS |
$385.49 |
$771,413 |
I/I |
(2,000) |
46,980 |
|
1% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2020-06-10 |
4 |
AS |
$385.22 |
$154,088 |
D/D |
(400) |
22,841 |
|
1% |
|
Kahn Barbara |
Director |
|
2020-06-10 |
4 |
AS |
$372.61 |
$2,665,001 |
I/I |
(7,000) |
6,879 |
|
1% |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2020-06-09 |
4 |
AS |
$375.36 |
$187,680 |
D/D |
(500) |
29,176 |
|
3% |
|
Sayer Kevin R |
President, CEO and Chairman |
|
2020-06-01 |
4 |
AS |
$372.47 |
$2,259,400 |
D/D |
(6,000) |
158,542 |
|
7% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2020-05-26 |
4 |
S |
$408.49 |
$602,114 |
D/D |
(1,474) |
23,241 |
|
2% |
|
Augustinos Nicholas |
Director |
|
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
806 |
806 |
|
- |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2020-05-22 |
4 |
AS |
$396.74 |
$607,409 |
I/I |
(1,531) |
6,122 |
|
-4% |
|
Foletta Mark G |
Director |
|
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
895 |
895 |
|
- |
|
Skyler Jay S |
Director |
|
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
822 |
822 |
|
- |
|
1713 Records found
|
|
Page 18 of 69 |
|
|